Grants per year
Fingerprint
Dive into the research topics where Charles Drescher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
Drescher, C., Alluri, K., Conlin, A., Bridges, B., Goodman, G., Lanier, K. S., Montgomery, P., Alluri, N. N. & Zuckerman, D. S.
08/1/14 → 07/31/24
Project: Research
-
Fred Hutchinson Breast Cancer Clinical Validation Center
Li, C. C. I., Drescher, C., Lampe, P. P. D., Partridge, S. S. C., Lampe, P. D. & Li, C. I.
08/16/10 → 07/31/24
Project: Research
-
-
Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V
Drescher, C. & Gambhir, S. S.
07/1/09 → 06/30/14
Project: Research
-
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer
Young Han, C., Bedia, J. S., Yang, W. L., Hawley, S. J., Bergan, L., Hopper, M., Celestino, J., Guo, J., Gornet, T. G., Soosaipillai, A., Yang, H., Doskocil, S. D., Lokshin, A. E., Handy, B. C., Diamandis, E. P., Moore, R. G., Lu, K. H., Lu, Z., Anderson, K. S., Drescher, C. W., & 2 others , 2024, (Accepted/In press) In: British Journal of Cancer.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer (Cell (2023) 186 16 (3476-3498.e35) PII: S0092-8674(24)00053-9)
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A., Savage, S. R., Berry, A. B., Reva, B., Ozbek, U., Krek, A., Ma, W., da Veiga Leprevost, F., Ji, J., Yoo, S., Lin, C., Voytovich, U. J., Huang, Y., & 27 others , Feb 15 2024, In: Cell. 187, 4, p. 1016 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A., Savage, S. R., Berry, A. B., Reva, B., Ozbek, U., Krek, A., Ma, W., da Veiga Leprevost, F., Ji, J., Yoo, S., Lin, C., Voytovich, U. J., Huang, Y., & 27 others , Aug 3 2023, In: Cell. 186, 16, p. 3476-3498.e35Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses
Irajizad, E., Han, C. Y., Celestino, J., Wu, R., Murage, E., Spencer, R., Dennison, J. B., Vykoukal, J., Long, J. P., Do, K. A., Drescher, C., Lu, K., Lu, Z., Bast, R. C., Hanash, S. & Fahrmann, J. F., Nov 1 2022, In: Clinical Cancer Research. 28, 21, p. 4669-4676 8 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Cancer case trends following the onset of the COVID-19 pandemic: A community-based observational study with extended follow-up
Drescher, C. W., Bograd, A. J., Chang, S. C., Weerasinghe, R. K., Vita, A. & Bell, R. B., Apr 1 2022, In: Cancer. 128, 7, p. 1475-1482 8 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations